Projects funded by the NCN
Assessment of the potential development of novel antibody fragments targeting IL13Rα2 using the phage display technique and 'in house" constructed antibody libraries as a tool for glioblastoma multiforme immunotherapy
2023/49/N/NZ5/02134
Keywords:
Glioblastoma immunotherapy mAbs scFv phage display IL13Rα2,
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_3: Pathogenesis of human diseases
- NZ1_5: Genetic engineering
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu
woj. dolnośląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 22 - announced on 2023-03-16
Amount awarded: 209 230 PLN
Project start date (Y-m-d): 2024-10-01
Project end date (Y-m-d): 2027-09-30
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.